Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro
Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Juan Antonio García-Arnés, Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Inmaculada González-Molero, Miguel Á. Japón(Instituto de Biomedicina de Sevilla), Eva Venegas‐Moreno(Hospital Universitario Virgen del Rocío), Esther Rivero‐Cortés(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Andrés de la Riva(Hospital Universitario Reina Sofía), Inmaculada Gavilán-Villarejo(Hospital Universitario Puerta del Mar), Alfonso Soto‐Moreno(Instituto de Biomedicina de Sevilla), Luis Jiménez‐Reina(University of Córdoba), Herbert Schmid(Novartis (Switzerland)), Silvia Maraver-Selfa(Hospital Clínico Universitario Virgen de la Victoria), Miguel Ángel Escribano Arráez(Hospital Sant Joan de Déu Barcelona), Mari C. Vázquez‐Borrego(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), María A. Gálvez(Hospital Universitario Reina Sofía), Raúl M. Luque(Instituto de Salud Carlos III)
Cited by 74
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251